Healthcare DIVE July 2, 2020
Samantha Liss

Dive Brief:

  • The COVID-19 pandemic did not stall mergers and acquisitions in the second quarter as much as some analysts had originally expected, according to the latest report from consultancy Kaufman Hall. In fact, the group says it expects a “significant uptick in M&A activity to be just ahead of us.”
  • During the second quarter, 14 transactions were announced. That’s a significant slowdown from the first quarter of this year, which saw 29 transactions, but just slightly down from the second quarter of 2019, which had 19. The quarter netted some of the highest figures Kaufman has recorded for average seller size at more than $800 million.
  • For-profit operators made up the majority of announced deals, accounting for nine...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Healthcare System, Mergers & Acquisitions / JV, Provider, Public Health / COVID, Survey / Study, Trends
In the Pipeline: LifeSpire of Virginia Announces $80M Renovation Plan; Oak Trace Completes Multiphase $112M Campus Redevelopment
Boston Scientific’s $3.7B Axonics buy tops list of medtech M&A in 2024
Digital health venture capital deals stagnate
Ascension continues selling spree
Acadia Executes 3 New Acquisitions, Fueling 2024 Growth Strategy

Share This Article